This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 May 21;360(21):2237-40.

doi: 10.1056/NEJMe0902632.

Optimal management of acute coronary syndromes

L David Hillis, Richard A Lange

PMID: 19458369
DOI: 10.1056/NEJMe0902632

Editorial

Optimal management of acute coronary syndromes

L David Hillis et al. N Engl J Med. 2009.

. 2009 May 21;360(21):2237-40.

doi: 10.1056/NEJMe0902632.

Authors

L David Hillis, Richard A Lange

PMID: 19458369
DOI: 10.1056/NEJMe0902632

No abstract available

PubMed Disclaimer

Comment in

Acute coronary syndromes.
Cequier A, Gómez-Hospital JA, Gonzalez-Costello J. Cequier A, et al. N Engl J Med. 2009 Aug 27;361(9):926; author reply 927. N Engl J Med. 2009. PMID: 19714783 No abstract available.
Acute coronary syndromes.
Shojai S. Shojai S. N Engl J Med. 2009 Aug 27;361(9):926; author reply 927. N Engl J Med. 2009. PMID: 19714784 No abstract available.

Comment on

Early versus delayed, provisional eptifibatide in acute coronary syndromes.
Giugliano RP, White JA, Bode C, Armstrong PW, Montalescot G, Lewis BS, van 't Hof A, Berdan LG, Lee KL, Strony JT, Hildemann S, Veltri E, Van de Werf F, Braunwald E, Harrington RA, Califf RM, Newby LK; EARLY ACS Investigators. Giugliano RP, et al. N Engl J Med. 2009 May 21;360(21):2176-90. doi: 10.1056/NEJMoa0901316. Epub 2009 Mar 30. N Engl J Med. 2009. PMID: 19332455 Clinical Trial.
Early versus delayed invasive intervention in acute coronary syndromes.
Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J, Natarajan MK, Horsman C, Fox KA, Yusuf S; TIMACS Investigators. Mehta SR, et al. N Engl J Med. 2009 May 21;360(21):2165-75. doi: 10.1056/NEJMoa0807986. N Engl J Med. 2009. PMID: 19458363 Clinical Trial.

Similar articles

Clinical policy: critical issues in the evaluation and management of adult patients with non-ST-segment elevation acute coronary syndromes.
Fesmire FM, Decker WW, Diercks DB, Ghaemmaghami CA, Nazarian D, Brady WJ, Hahn S, Jagoda AS; American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Non-ST-Segment Elevation Acute Coronary Syndromes. Fesmire FM, et al. Ann Emerg Med. 2006 Sep;48(3):270-301. doi: 10.1016/j.annemergmed.2006.07.005. Ann Emerg Med. 2006. PMID: 16934648 No abstract available.
Optimizing antiplatelet therapy for the ACS patient: reacting to clinical trial data from the ISAR-REACT-2 studies.
Steinhubl SR. Steinhubl SR. Rev Cardiovasc Med. 2006;7 Suppl 4:S12-9. Rev Cardiovasc Med. 2006. PMID: 17224886 Review.
Managing unstable angina in high-risk patients.
Chew DP, Moliterno DJ. Chew DP, et al. J Invasive Cardiol. 2002 Feb;14 Suppl A:31A-48A. J Invasive Cardiol. 2002. PMID: 11847404 Review. No abstract available.
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
O'Donoghue M, Antman EM, Braunwald E, Murphy SA, Steg PG, Finkelstein A, Penny WF, Fridrich V, McCabe CH, Sabatine MS, Wiviott SD. O'Donoghue M, et al. J Am Coll Cardiol. 2009 Aug 18;54(8):678-85. doi: 10.1016/j.jacc.2009.05.025. J Am Coll Cardiol. 2009. PMID: 19679245 Clinical Trial.
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, DeLucca PT, DiBattiste PM, Gibson CM, Braunwald E; TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)--Thrombolysis in Myocardial Infarction 18 Investigators. Cannon CP, et al. N Engl J Med. 2001 Jun 21;344(25):1879-87. doi: 10.1056/NEJM200106213442501. N Engl J Med. 2001. PMID: 11419424 Clinical Trial.

See all similar articles

Cited by

Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor.
Birkeland K, Parra D, Rosenstein R. Birkeland K, et al. J Blood Med. 2010;1:197-219. doi: 10.2147/JBM.S9650. Epub 2010 Sep 1. J Blood Med. 2010. PMID: 22282698 Free PMC article.
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal.
Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Kent DM, et al. Trials. 2010 Aug 12;11:85. doi: 10.1186/1745-6215-11-85. Trials. 2010. PMID: 20704705 Free PMC article.
Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Parikh SV, Keeley EC. Parikh SV, et al. Vasc Health Risk Manag. 2009;5:677-91. doi: 10.2147/vhrm.s4828. Epub 2009 Aug 20. Vasc Health Risk Manag. 2009. PMID: 19707287 Free PMC article. Review.
Comparison of RISK-PCI, GRACE, TIMI risk scores for prediction of major adverse cardiac events in patients with acute coronary syndrome.
Jakimov T, Mrdović I, Filipović B, Zdravković M, Djoković A, Hinić S, Milić N, Filipović B. Jakimov T, et al. Croat Med J. 2017 Dec 31;58(6):406-415. doi: 10.3325/cmj.2017.58.406. Croat Med J. 2017. PMID: 29308832 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.